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Even though stroke is known to be a common cause of status epilepticus (SE), the types of stroke or SE that may be associated
are not yet clearly defined. The aims of this study were to assess the timing and type of SE in stroke patients and to observe the
effects of stroke and the type of SE on the response to treatment and mortality.
From May 1998 to May 2001 a total of 121 patients were admitted with SE. Among these, 30 cases (24.8%) of poststroke SE
were identified and evaluated. There were 20 early-onset, and 10 late-onset SE. All stroke types were evenly distributed within
the early-onset group, whereas only ischaemic stroke was found in the late-onset group. Posterior cerebral artery (PCA) infarcts
were significantly more common within the latter (P: 0.0017).
Nonconvulsive SE (NCS) was more frequent than convulsive SE (CS) in the early-onset group (P: 0.0352). There was a delay
in the time-to-treatment for NCS compared to CS (P: 0.0007). Without, however any effect on the rate of response to first step
treatment (intravenous diazepam and phenytoin; P: 0.6334). Thirteen patients died (43.3%) during hospitalisation. Disability was
significantly associated with higher mortality in the early-onset group (P: 0.0201). As a conclusion, NCS seems to be an important
issue in stroke, thus requiring a high degree of suspicion in an acute stroke setting to avoid further neuronal injury and morbidity.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Stroke is known to be a common risk factor for sta-
tus epilepticus (SE) in adults1, 2 and has been reported
in 22–32% of cases in different studies3, 4. The inci-
dence of seizures associated with stroke varies from
4.4 to 54% due to differences in definition and study
settings5–14. Furthermore, SE is infrequently reported
in poststroke seizures series, and constitutes less than
10% of all cases9, 15. However, recent studies have
found slightly higher rates such as 14–27% in patients
with cerebrovascular disease16–18 and 17% in patients
with intracerebral haemorrhage7. Moreover, the inci-
dence of SE is fairly low in large stroke series, rang-
ing from none19, through 0.9%7, 8, 17, 20 to 1.4% in a
recent study21. The aims of the present study were to
investigate the timing and type of SE associated with
acute or chronic stroke; and to determine the possible
effects of the SE or stroke type, and lesion localisation
on the response to treatment and mortality.
METHODS
The study population was derived from the Marmara
University Hospital SE Data Bank which prospec-
tively included all SE patients admitted to the hospital
from May 1998 to May 2001. This hospital-based
Data Bank included information on the duration and
type of SE, underlying factors such as structural
deficits or medical pathologies, history of epilepsy and
demographic data. Thirty consecutive patients with
poststroke SE were identified among a total of 121
patients. SE was defined as unremitting seizure activ-
ity or series of seizures lasting for more than 5 min22.
Patients were evaluated by a standard protocol includ-
ing EEG, neuroimaging (CT or MRI), and routine
blood testing. EEG was available on a 24 h basis 7
days a week, allowing prompt assessment of all pa-
tients developing an acute confusional state. Patients
were grouped as having initial (occurring at stroke
onset), early-onset (occurring within 2 weeks of the
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stroke), and late-onset (occurring more than 2 weeks
of the stroke) SE23. SE was further subgrouped into
convulsive or nonconvulsive according to the clinical
and EEG findings. Nonconvulsive SE (NCS) was de-
fined as an alteration of consciousness lasting at least
30 min with persistent or continuous epileptiform dis-
charges in the EEG, with or without suppression of
this activity by intravenous diazepam. NCS was fur-
ther subgrouped according to a modified classification
from Brodtkorb et al.24 and Treiman25 as follows:
NCS following complex partial seizure NCS follow-
ing simple partial seizure subdinic EEG lateralisation
and undetermined NCS. Stroke was subdivided into
ischaemic and haemorrhagic type. Ischaemic stroke
was classified according to arterial localisation, into
middle cerebral artery (MCA), posterior cerebral
artery (PCA), or other (multiple or other localisation)
infarcts. Similarly, haemorrhagic stroke was subdi-
vided into lobar or deep localisation. SE treatment was
performed according to a stepwise standard protocol
intravenous diazepam and phenytoin as the first step,
repeated intravenous phenytoin as the second step, in-
travenous phenobarbital (1 or 2 times) as the third step,
and intravenous midazolam or propofol as the fourth
step. Convulsive and NCS were analysed according
to their association with different stroke types. Differ-
ences in response to treatment and mortality rates were
analysed among different SE and stroke subtypes and
for demographic variables. Statistical analysis was
made with Student’s t-test for normally distributed
continuous random variables, and the Mann–Whitney
U-test for nonnormally distributed continuous random
variables. The Fisher’s exact test was used for discrete
random variables and the odds ratio was calculated.
RESULTS
There were 30 patients (25 women and 5 men) out
of 121 in the SE data bank (24.8% of all SE) associ-
ated with stroke, with a mean age of 73.6±8.8 (range
50–89). Five patients had initial SE, 15 had early-onset
SE and 10 had late-onset SE, 22 patients had NCS, 8
had convulsive SE (CS). Two patients had NCS fol-
lowing a complex partial seizure one had NCS follow-
ing a simple partial seizure, 13 had subclinical EEG
lateralisation, and 6 had undetermined NCS.
Patients with initial and early SE constituted 2.8%
of the 715 patients from the Stroke Data Bank of our
Institution evaluated during the same period of time.
Only two patients had a history of previous seizures
and the SE episode was considered to be a first-time
seizure. The detailed distribution of SE and stroke
types is shown in Table 1. Ischaemic stroke type was
predominant among all SE subgroups and was present
in 5 out of 5 in initial, in 8 of 15 in early, and in 9
Table 1: Distribution of nonconvulsive SE, convulsive SE, and
type of stroke among initial, early- and late-onset patients.
Initial SE, Early-onset SE, Late-onset SE,
n: 5 n: 15 n: 10
NCS (n: 21)a
Ischaemic 3 8 5
Haemorrhagic – 6 –
CS (n: 9)
Ischaemic 2 – 5
Haemorrhagic – 1 –
SE: status epilepticus; NCS: nonconvulsive SE; CS: convulsive
SE.
a NCS significantly more common in early group (P: 0.0352;
OR: 12.250).
of 9 in late SE groups. The stroke severity as a whole
was quite important with a median NIH stroke scale
(NIHSS) of 16.7±4.5. The distribution of NCS and CS
among SE groups was as follows; 3 and 2 in the initial
SE, 14 and 1 in the early-onset, and 5 and 5 in the
late-onset groups, respectively. NCS was significantly
more frequent within the early-SE group compared to
the 2 others (P: 0.0352; OR: 12.250).
Lesion localisation in the early- and late-onset SE
group is summarised in Table 2. For further analy-
sis, patients with initial SE was considered together
with the early-onset SE group due to the limited
number of cases. All stroke subtypes were evenly dis-
tributed within the early-onset group, whereas only
ischaemic stroke subtypes were found in the late-onset
group. PCA infarcts were significantly more common
within the late-onset group (P: 0.0017; OR: 21.000).
The detailed comparison between the NCS and
CS groups as to disability, time-to-treatment, and re-
sponse to treatment is summarised in Table 3. There
was a striking delay in the time-to-treatment for the
NCS group. This difference disappeared when the late
group was analysed alone (12.4 ± 9.0 vs. 3.8 ± 1.6
P: 0.22). No significant difference was found in
time-to-treatment between the early- and late-onset
groups (P: 0.4008). It is also noteworthy that the delay
in treatment seemed to be greater for MCA infarcts
compared to PCA infarcts (36.0±16.9 vs. 12.7±9.6),




Early-onset SE Late-onset SE
NCS CS NCS CS
MCA 4 2 – 3
PCAa 2 – 5 2
Other ischaemic 5 – – –
Haemorrhage: lobar 4 1 – –
Haemorrhage: deep 2 – – –
SE: status epilepticus; NCS: nonconvulsive SE; CS: convulsive
SE; MCA: middle cerebral artery; PCA: posterior cerebral artery.
a PCA infarcts significantly more frequent in late group (P:
0.0017; OR: 21.000).
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Table 3: Detailed comparison between nonconvulsive SE
and convulsive SE groups as to disability, time-to-treatment




16.1 ± 4.8 18.6 ± 2.8 0.2188
Time-to-treatment (hours) 18.8 ± 14.6 4.1 ± 3.6 0.0007
Early SE group 20.6 ± 15.6 4.7 ± 6.3 0.4008
MCA 36.0 ± 17.8 2.6 ± 1.7 0.0159
PCA 12.7 ± 9.6 4.0 ± 2.8 0.2635
Response to first line
treatment
74% 87% 0.6334
NIHSS: NIH stroke scale; NCS: nonconvulsive SE; CS:
convulsive SE; MCA: middle cerebral artery; PCA: posterior
cerebral artery; numbers: mean± SD.
however limited number of cases precluded statisti-
cal analysis. Moreover, when early- and late-onset
groups were analysed separately, a tendency toward
a longer delay for treatment in the early-onset group
was observed (18.2 ± 15.6 vs. 8.1 ± 7.6 h; P: 0.09).
The average time-to-treatment was 19.0 ± 17.9 h for
‘other’ infarcts and 14.1 ± 5.6 h for haemorrhagic
lesions. No further analysis was performed due to the
limited number of patients in different subgroups.
Twenty-one out of 30 (70%) of the patients, whether
in the NCS or CS groups, responded similarly to the
first step of SE treatment. Among the others, three pa-
tients responded at the 2nd and six patients responded
at a higher step or were refractory to treatment. There
was no significant difference in the time-to-treatment
between the first step responders and higher than the
2nd step responders either in the early-onset NCS
group (17.4 ± 15.1 vs. 26.4 ± 16.2 h; P: 0.2787) or
in the whole group (13.0 ± 13.9 vs. 22.5 ± 17.4 h;
P: 0. 1762). Despite significant delay in treatment for
the NCS patients, no difference in the response to
treatment was observed between NCS and CS patients
(73.7 vs. 87.5%; P: 0.6334).
Furthermore, neither the type of stroke (MCA vs.
PCA infarct; 66.7 vs. 100%; P: 0.2059), the disability
(NIHSS score 17.8 ± 3.6 vs. 16.5 ± 4.8; P: 0.5124),
and age (73.6±9.3 vs. 75.8±7.3; P: 0.6289) had any
effect on the response to treatment.
Thirteen out of 30 patients (43.3%) died during hos-
pitalisation, ten with NCS (two with NCS following
partial seizures, four with subclinical EEG laterali-
sation, and four with undetermined NCS) and three
with CS (Table 4). No further analysis to determine
differences in mortality rates among NCS subgroups
was performed due to the small number of patients.
Eight of those who died were in the early-onset group
and had severe or multiple ischaemic lesions, a large
haematoma and underlying chronic medical illnesses.
Five patients of the late-onset group had ischaemic
lesions and died directly due to their SE, with the ex-
ception of one patient in chronic renal failure. Dis-
Table 4: Timing of SE, type of SE, type of stroke, lesion
localisation and correlation with mortality rates.
Mortality, n (%) P
Timing of SE
Early 8 (40.0) 0.7055
Late 5 (50.0)
Type of SE
NCS 10 (45.5) 1.0000
CS 3 (37.5)
Type of stroke
Ischaemic 10 (43.5) 1.0000
Haemorrhagic 3 (42.8)
Lesion localisation
MCA 2 (22.2) 0.3348
PCA 5 (55.5)
NCS: nonconvulsive SE; CS: convulsive SE; MCA: middle
cerebral artery; PCA: posterior cerebral artery.
Table 5: Relationship between mortality, NIH stroke scale
scores, age, and time-to-treatment.
Survivora Deada P
NIHSS scores 15.3 ± 4.8 18.6 ± 3.3 0.0898
Early SE group 14.2 ± 5.0 19.6 ± 3.7 0.0201
Age (years) 74.5 ± 9 72.4 ± 9 0.5294
Time-to-treatment (hours) 17.7 ± 14.1 17.2 ± 13.1 0.9306
a Mean± SD; NIHSS: NIH stroke scale.
ability (higher NIHSS scores) was significantly asso-
ciated with higher mortality in the early-onset group
(score: 19.6 ± 3.7 vs. 14.2 ± 5.0; P: 0.0201) but not
in the whole group (score: 18.6± 3.3 vs. 15.3± 4.8;
P: 0.0898). Although there was a strikingly high rate
mortality within the late-onset NCS subgroup com-
pared to the CS group (80 vs. 20%), this did not reach
statistical significance (P: 0.2063, OR: 16.000) due to
the small sample size. On the other hand, neither the
type or localisation of the stroke, timing of SE, de-
lay in time-to-treatment or age significantly affected
mortality (Table 5).
DISCUSSION
This study emphasises once more that stroke is an im-
portant factor in the aetiology of SE, as demonstrated
by the 24.8% incidence in our series of 121 patients
with SE. Furthermore, independent of the timing of
SE onset, NCS was more frequent among these pa-
tients, challenging the issue of diagnosis in an acute
stroke setting. Several points are worth discussing in
this aspect.
Type of status epilepticus
The type of SE associated with stroke is unfortunately
not mentioned in most studies7, 8, 19–21. In others,
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however, CS is either reported to be exclusively
present18 or more frequent compared to NCS17. In the
present study, NCS was the predominant type in the
early-onset group (85%) and was as frequent as CS
(50%) in the late-onset group. These high rates em-
phasise once more the importance of NCS in patients
with cerebrovascular disease and the necessity of a
high degree of suspicion in order to allow accurate
diagnosis.
Type and localisation of stroke
Although different studies have affirmed that post-
stroke seizures were mostly related to haemorrha-
gic6, 8, 10 or ischaemic stroke12, recently published
large stroke series failed to demonstrate a relation be-
tween stroke type and seizure or SE occurrence17, 21.
The present study could not demonstrate an associa-
tion between early-onset SE and stroke type, however
the absence of haemorrhagic stroke in the late-onset
SE group was noteworthy. Previous reports have as-
sociated cortical lesions15, 26, 27 or carotid territory
lesions20, 28 with poststroke seizures. However, two
recent studies denied any relation between locali-
sation and SE occurrence17, 21 and one study could
only correlate SE to lobar lesions18. Similarly, no
particular site was associated with early-onset SE in
our study, but PCA infarcts were significantly more
frequent in the late-onset group. However, the limited
number of patients precludes further comment.
Outcome
We observed an overall good response to the first step
of SE treatment in all patients. This study failed to
demonstrate other factors influencing the response to
treatment (age, stroke severity localisation, or type of
SE). The prominent delay in time-to-treatment within
the early-onset NCS group did not, surprisingly, influ-
ence the response to treatment or the mortality. How-
ever, this delay could still be important in regards to
neurobehavioural sequelae or a lower quality of life of
survivors. Our study design did not include such data
and this area may be worth investigating.
The mortality among our patients (44.8%) is appar-
ently higher than the rates given in recent studies that
ranged between 8 and 38%3, 29. However, these stud-
ies included all aetiologies of SE together and were
generally of CS. Two recent studies dealing with SE
in stroke patients reported mortality rates of 48.317
and 53%21, respectively. Moreover, similarly high
mortality rates were demonstrated among SE patients
associated with organic brain disease30 or stroke31
as compared with those patients with no underlying
pathology, emphasising the possible synergistic ef-
fect of SE and a destructive brain lesion. Similarly,
Claassen et al. determined that acute symptomatic
seizures were independent predictors of mortality32.
We found no association between mortality and SE
timing or type, stroke type or localisation, age or
delay to treatment. However, we found stroke sever-
ity to be associated with increased mortality in the
early-onset group. Several reports point to the possi-
ble deleterious role of early seizures or SE in stroke
patients33–35. Moreover, Labovitz et al.18 pointed
out a possible relationship between stroke severity
or NIHSS scores and mortality. Veliog˘lu et al.21
also suggested an association of SE with increased
disability but not mortality in a stroke setting.
CONCLUSIONS
The results of our study suggest that NCS could be
important in the acute stroke setting further increas-
ing neuronal injury and hence morbidity. Therefore,
patients with severe stroke would benefit from an
EEG in any case of unexplained changes in con-
sciousness. Moreover, patients having a history of
severe ischaemic stroke (especially in MCA and PCA
territories) should be thoroughly investigated if con-
sciousness or behaviour change suddenly in order not
to miss a NCS. Consequently, the potential associa-
tion of late SE with certain stroke localisation’s may
require further prospective studies.
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